Sputum-Based Molecular Biomarkers for the Early Detection of Lung Cancer: Limitations and Promise
Lung cancer is the leading cause of cancer deaths, with an overall survival of 15% at five years. Biomarkers that can sensitively and specifically detect lung cancer at early stage are crucial for improving this poor survival rate. Sputum has been the target for the discovery of non-invasive biomark...
Main Authors: | William N. Rom, Kam-Meng Tchou-Wong, Connie E. Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/3/3/2975/ |
Similar Items
-
An evaluation of methods of inducing sputum production in patient with suspected lung cancer
by: Maha Shakir Hassan
Published: (2007-01-01) -
Microbiota Biomarkers for Lung Cancer
by: Qixin Leng, et al.
Published: (2021-02-01) -
Tissue hyaluronan expression, as reflected in the sputum of lung cancer patients, is an indicator of malignancy
by: M.P. Rangel, et al.
Published: (2015-05-01) -
Detection of early-stage lung cancer in sputum using automated flow cytometry and machine learning
by: Madeleine E. Lemieux, et al.
Published: (2023-01-01) -
diaPASEF Proteomics and Feature Selection for the Description of Sputum Proteome Profiles in a Cohort of Different Subtypes of Lung Cancer Patients and Controls
by: María del Sol Arenas-De Larriva, et al.
Published: (2022-08-01)